Within the 2011–2012 cohort, patients within the OEG were predominantly older (median age: 62), female (67%), possessed right sided tumours (89%), with deficient MLH1 (56%) expression, of which 60% harboured BRAF mutations. The gene discussed is BRAF; the disease is neoplasm.